Vanda reports vomiting in 43% of tradipitant users versus 58.5% on placebo after a single 1 mg semaglutide dose, and plans to take the data to the FDA.
Recap by typeshit. Full story at Morningstar.
A Facebook share says Danish teams found certain bacterial strains may change how the gut tells the brain it is full. The work so far is in animal models only.
Bikman calls the results remarkable, but he argues that bigger drops make it more important to know how much of the lost weight is fat and how much is muscle.
Bikman points out that weight usually returns once the drug is stopped, which makes the question of lifelong use a real one.
Avi Roy flags a preprint that pooled 10,052 people from five semaglutide trials and used a blood test to estimate heart age. It has not yet been peer reviewed.
A short social share on how the two semaglutide brands differ for diabetes and weight loss. Thin on detail, so tap through for the full comparison.
A shared guide on adjusting exercise while on GLP-1 medication. Only the title came through, so tap through for the actual advice.
Loading…